Language

COVID-19 Vaccine Updates

We are not currently scheduling patients for COVID-19 vaccines. Please help us keep our phone lines open. Do not call to ask for vaccine updates. We will keep you informed as we learn more. The most up-to-date vaccine information is available on our vaccine page.

More COVID-19 resources: Testing & Treatment | Visiting MultiCare

Close

Nehal Masood, MD, MBBS

Nehal  Masood, MD

Nehal Masood, MD, MBBS

Oncology/Hematology (Cancer and Blood Disorders)

Accepting New Patients

Virtual Visits Available

Phone: 253-403-1677    Fax: 253-403-3555

Call For an Appointment

Provider Details

Certification: American Board of Internal Medicine: Medical Oncology

Medical Association Memberships: American Society of Clinical Oncology American Society of Hematology

Languages: English, Hindu, Urdu

Practice Philosophy: I believe that everyone deserves to be treated with dignity and respect and when I interact wit patients and their loved ones, I understand that they are dealing with complex issues, looking for hope and need a physician who can help. I want to ensure that my patients have the knowledge they need to make the best decisions about treatment and care. In my practice, I use my training in areas such as molecular biology and genetics to help guide my decisions about a patient's care. There are far more treatment options available than ever before and I find it exciting to provide innovative, breakthrough care to my patients.

Professional School: Dow Medical College, Karachi, Pakistan

Residency: University of Chicago, Chicago, IL

Fellowship: Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA

Research & Publications

Chih-Hsin Yang J, Camidge DR, Yang CT, Zhou J, Guo R, Chiu CH, Chang GC, Shiah HS, Chen Y, Wang CC, Berz D, Su WC, Yang N, Wang Z, Fang J, Chen J, Nikolinakos P, Lu Y, Pan H, Maniam A, Bazhenova L, Shirai K, Jahanzeb M, Willis M, Masood N, Chowhan N, Hsia TC, Jian H, Lu S. Safety, Efficacy and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients with EGFR-mutated Advanced NSCLC: a Multicenter, Open-label, Phase I Trial. J Thorac Oncol. 2020 Sep 8:S1556-0864(20)30714-0. doi: 10.1016/j.jtho.2020.09.001. Epub ahead of print. PMID: 32916310. 

More Info

Nehal Masood, MD, is a board-certified oncologist who has cared for cancer patients for more than 25 years. He treats breast, colon, lung and kidney cancers and provides treatment for lymphomas and other hematological conditions. Dr. Masood is a frequent lecturer and is widely published. His cancer research has earned numerous awards. He is a member of the American Society of Clinical Oncology, the American Society of Hematology and the American Association for Cancer Research.

The services Dr. Masood provides include:

  • Cytotoxic chemotherapy
  • Immunotherapy
  • Stem cell therapy

Return to Search